Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer. - Camidge DR; Barlesi F; Goldman JW; Morgensztern D; Heist R; Vokes E; Spira A; Angevin E; Su WC; Hong DS; Strickler JH; Motwani M; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023)